University of Utah Huntsman Cancer Institute — Salt Lake City, Utah

Public research footprint of University of Utah Huntsman Cancer Institute, compiled from the ClinicalTrials.gov public registry.

164

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Locoregionally Recurrent Hormone-receptor Positive Breast Cancer · Resectable Pancreatic Ductal Adenocarcinoma (PDAC) · Acute Myeloid Leukemia · Metastatic Hormone Receptor Positive Breast Cancer

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT06465069 — A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or… (Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Utah Huntsman Cancer Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.